CareRx Corporation
CRRX.TO
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 265.05M | 261.98M | 262.37M | 263.52M | 267.68M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 265.05M | 261.98M | 262.37M | 263.52M | 267.68M |
| Cost of Revenue | 185.61M | 183.88M | 184.88M | 185.72M | 188.81M |
| Gross Profit | 79.44M | 78.10M | 77.48M | 77.81M | 78.87M |
| SG&A Expenses | 71.27M | 71.78M | 71.69M | 72.66M | 73.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 0.00 | 700.00 | -- | -- | -- |
| Total Operating Expenses | 256.88M | 255.66M | 256.58M | 258.38M | 262.70M |
| Operating Income | 8.17M | 6.32M | 5.79M | 5.14M | 4.98M |
| Income Before Tax | 2.42M | 108.20K | -1.28M | -2.69M | -3.24M |
| Income Tax Expenses | -16.34M | 22.90K | 22.90K | 22.90K | 22.90K |
| Earnings from Continuing Operations | 18.75 | 0.09 | -1.30 | -2.72 | -3.26 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 18.75M | 85.30K | -1.30M | -2.72M | -3.26M |
| EBIT | 8.17M | 6.32M | 5.79M | 5.14M | 4.98M |
| EBITDA | 18.29M | 14.65M | 14.64M | 15.42M | 16.20M |
| EPS Basic | 0.30 | 0.00 | -0.02 | -0.05 | -0.05 |
| Normalized Basic EPS | 0.03 | 0.01 | 0.00 | -0.01 | -0.02 |
| EPS Diluted | 0.29 | 0.00 | -0.02 | -0.05 | -0.06 |
| Normalized Diluted EPS | 0.03 | 0.01 | 0.00 | -0.01 | -0.02 |
| Average Basic Shares Outstanding | 251.57M | 249.65M | 246.75M | 243.88M | 241.02M |
| Average Diluted Shares Outstanding | 259.18M | 256.00M | 251.18M | 246.34M | 241.02M |
| Dividend Per Share | 0.03 | 0.01 | -- | -- | -- |
| Payout Ratio | 4.82% | -- | -- | -- | -- |